2 results
Approved WMOCompleted
Primary objectiveTo evaluate if tralokinumab after 14 weeks of treatment (at steady state) changes the metabolism of substrates of CYP 1A2, 2C9, 2C19, 2D6, or 3A4 pathways in subjects with moderate-tosevere atopic dermatitisSecondary objectivesTo…
Augmented Reality cues to reduce Freezing of Gait during turning in persons with Parkinson*s disease
The primary objective of this study is to investigate the effect of visual turning-cues presented in augmented reality on the severity of freezing of gait evoked during turning in patients with Parkinson*s disease. This effect is compared to that of…